menu
    • menu

    Company profile for MODAG

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MODAG focuses on research and development of therapeutics and diagnostics for neurodegenerative diseases. It is a privately held company located at the Hochtechnologiepark Wendelsheim, Germany with additional Research & Development facilities in Munich and Göttingen. MODAG’s innovative approach offers a unique combination of early diagnosis and targeted disease-modifying therapies for severe neurological disorders. MODAG´s...
    MODAG focuses on research and development of therapeutics and diagnostics for neurodegenerative diseases. It is a privately held company located at the Hochtechnologiepark Wendelsheim, Germany with additional Research & Development facilities in Munich and Göttingen. MODAG’s innovative approach offers a unique combination of early diagnosis and targeted disease-modifying therapies for severe neurological disorders. MODAG´s collaborations with top-tier US and European research institutions, combined with the interdisciplinary research and development expertise of the founder´s and the management team.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MODAGGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Mikroforum Ring 3 55234 Wendelsheim
    Telephone
    Telephone
    +49-6734-9622-8000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.modag.net/index.php/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MODAG initiates first-in-patient phase 1b trial for Anle138b
    MODAG initiates first-in-patient phase 1b trial for Anle138b

    23 Dec 2020

    // BUSINESS

    https://pharmaceutical-business-review.com/news/modag-initiates-first-in-patient-phase-1b-trial-for-anle138b-in-parkinsons-disease/

    BUSINESS
    23 Dec 2020
    Share Share
    MODAG initiates first-in-patient phase 1b trial for Anle138b in PD
    MODAG initiates first-in-patient phase 1b trial for Anle138b in PD

    23 Dec 2020

    // PHARMACEUTICAL-BUSINESSS

    https://pharmaceutical-business-review.com/news/modag-initiates-first-in-patient-phase-1b-trial-for-anle138b-in-parkinsons-disease/

    PHARMACEUTICAL-BUSINESSS
    23 Dec 2020
    Share Share
    MODAG Initiates First-in-Human Phase 1 Clinical Trial for Anle138b
    MODAG Initiates First-in-Human Phase 1 Clinical Trial for Anle138b

    18 Dec 2019

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20191218005234/en/MODAG-Initiates-First-in-Human-Phase-1-Clinical-Trial/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

    BUSINESS WIRE
    18 Dec 2019
    Share Share
    MODAG Initiates First-in-Human Phase 1 Clinical Trial for Anle138b
    MODAG Initiates First-in-Human Phase 1 Clinical Trial for Anle138b

    18 Dec 2019

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20191218005234/en

    BUSINESS WIRE
    18 Dec 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search